PH Grants Emergency Use of Authorization for Sinovac Vaccine

The Philippine Food and Drug Administration (FDA) has granted the Emergency Use of Authorization (EUA) for the China-based Sinovac COVID-19 Vaccine for the country’s national vaccination program set to roll out this month.

This was announced by FDA Director-General Dr. Eric Domingo today, February 22, 2021 (Monday), during the Laging Handa Public Briefing.

Furthermore, it was stated by Domingo that it was shown in the ongoing Phase 3 trial of Sinovac that it has an efficacy of 65.3 to 91.2 percent after the first dose when used on clinically healthy members of the community age 18 to 59.

“It is decided that all conditions for an EUA are present and that the benefit of using the vaccine outweighs the known potential risks. The interim data from the ongoing Phase 3 trial shows that when the vaccine is used on clinically healthy members of the community age 18 to 59, it has an efficacy of 65.3 to 91.2 percent after the first dose.”

-FDA Director General Domingo  | PNA

Related Articles:

Pfizer and BioNTech Announced Start of Trial of COVID-19 Vaccine in Pregnant Women

WHO Approves AstraZeneca Vaccine for Emergency Use

3 Vaccines Granted EUA in PH

For more information, see our complete guide on PMA Entrance Exam Results 2019| PMAEE 2019 List of Passers.